Dr. Kimberly A. Brown, M.D.
Gastroenterology (Gastroenterology Physician)
Henry Ford Health System, 2799 West Grand Boulevard
Detroit, MI 48202
- Medicare participating
At a glance
- Medical school
- Wayne State University School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 150
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: Wayne State University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
MI license 4301405859 -
Transplant Hepatology Physician
MI license 4301405859
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Henry Ford Health Hospital Detroit, MI
- Henry Ford Macomb Hospital Clinton Township, MI
- Henry Ford Health West Bloomfield Hospital W Bloomfield, MI
- Henry Ford Allegiance Health Jackson, MI
- Wyandotte Hospital and Medical Center Wyandotte, MI
Medical groups
- Henry Ford Health System (2,570 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 150
- Services billed
- 329
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 80 | 70 |
| Established patient office or other outpatient visit, 30-39 minutes | 29 | 28 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 28 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 18 | 18 |
| Measurement of liver stiffness | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ursodiol Other prescribers in Detroit, MI | 343 |
| Mycophenolate Mofetil Other prescribers in Detroit, MI | 191 |
| Tacrolimus Other prescribers in Detroit, MI | 180 |
| Xifaxan (rifaximin) Other prescribers in Detroit, MI | 96 |
| Prednisone Other prescribers in Detroit, MI | 67 |
| Furosemide Other prescribers in Detroit, MI | 66 |
| Azathioprine Other prescribers in Detroit, MI | 58 |
| Cyclosporine Modified (cyclosporine, modified) | 48 |
| Spironolactone Other prescribers in Detroit, MI | 46 |
| Carvedilol Other prescribers in Detroit, MI | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 69 payments worth $157,021 in total to this clinician.
| Madrigal Pharmaceuticals | $45,482 |
|---|---|
| Gilead Sciences, Inc. | $45,218 |
| Mallinckrodt Hospital Products Inc. | $29,109 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20,440 |
| Intercept Pharmaceuticals, Inc. | $7,339 |
| Ipsen Biopharmaceuticals, Inc | $4,590 |
| GlaxoSmithKline, LLC. | $4,000 |
| Bausch Health US, LLC | $800 |
| Compensation for services other than consulting (speaking, faculty) | $104,847 |
|---|---|
| Consulting Fee | $38,670 |
| Travel and Lodging | $6,485 |
| Speaking at a medical education program | $4,960 |
| Food and Beverage | $2,060 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Mar 19, 2025 | Consulting Fee REZDIFFRA · LIVER DISEASE | $8,460 |
| Mallinckrodt Hospital Products Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $8,280 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) XIFAXAN · Gastroenterology | $7,200 |
| Mallinckrodt Hospital Products Inc. Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $6,900 |
| Gilead Sciences, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4113061;AHM;10003083 | $6,440 |
| Gilead Sciences, Inc. Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4121644;AHM;10003083 | $6,440 |
| Gilead Sciences, Inc. Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4282030;AHM;10003083 | $6,440 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Jul 31, 2025 | Consulting Fee | $6,400 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Jul 31, 2025 | Consulting Fee | $6,400 |
| Mallinckrodt Hospital Products Inc. Sep 9, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $5,520 |
All 47 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $2,468 |
| Mallinckrodt Hospital Products Inc. Nov 5, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $5,520 |
| Gilead Sciences, Inc. Nov 3, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Fayetteville, NY · in-kind Company’s description;4328137;AHM;10003083 | $888 |
| Gilead Sciences, Inc. Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4282030;AHM;10003083 | $6,440 |
| Gilead Sciences, Inc. Oct 30, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Fayetteville, NY · in-kind Company’s description;4281870;AHM;10003083 | $233 |
| Gilead Sciences, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4249409;GTF;10003083 | $600 |
| Gilead Sciences, Inc. Oct 20, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Fayetteville, NY · in-kind Company’s description;4281913;AHM;10003083 | $757 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) XIFAXAN · Gastroenterology | $7,200 |
| Gilead Sciences, Inc. Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4182069;AHM;10003083 | $4,930 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Oct 6, 2025 | Travel and Lodging XIFAXAN · Gastroenterology · travel to Lima, OH | $86.10 |
| Madrigal Pharmaceuticals Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| GlaxoSmithKline, LLC. Sep 22, 2025 | Consulting Fee | $4,000 |
| Mallinckrodt Hospital Products Inc. Sep 9, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $5,520 |
| Gilead Sciences, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4257282;AHM;10003083 | $3,790 |
| Mallinckrodt Hospital Products Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $8,280 |
| Intercept Pharmaceuticals, Inc. Aug 21, 2025 | Speaking at a medical education program OCALIVA · Hepatology / Gastroenterology | $4,960 |
| Intercept Pharmaceuticals, Inc. Aug 21, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Columbus, OH · in-kind | $397 |
| Mallinckrodt Hospital Products Inc. Aug 20, 2025 | Travel and Lodging TERLIVAZ · CRITICAL CARE · travel to METAIRIE, LA · in-kind | $232 |
| Mallinckrodt Hospital Products Inc. Aug 18, 2025 | Travel and Lodging TERLIVAZ · CRITICAL CARE · travel to METAIRIE, LA · in-kind | $467 |
| Gilead Sciences, Inc. Aug 15, 2025 | Consulting Fee Vemlidy · HBV Company’s description;4174356;VEM US;10003083 | $5,230 |
| Madrigal Pharmaceuticals Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $2,115 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Jul 31, 2025 | Consulting Fee | $6,400 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC Jul 31, 2025 | Consulting Fee | $6,400 |
| Gilead Sciences, Inc. Jul 30, 2025 | Travel and Lodging Vemlidy · HBV · travel to Anaheim, CA · in-kind Company’s description;4174551;VEM US;10003083 | $304 |
| Gilead Sciences, Inc. Jul 30, 2025 | Travel and Lodging Vemlidy · HBV · travel to Anaheim, CA · in-kind Company’s description;4174490;VEM US;10003083 | $219 |
| Gilead Sciences, Inc. Jul 29, 2025 | Travel and Lodging Vemlidy · HBV · travel to Anaheim, CA · in-kind Company’s description;4174476;VEM US;10003083 | $231 |
| Gilead Sciences, Inc. Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4113837;AHM;10003083 | $1,900 |
| Gilead Sciences, Inc. Jun 27, 2025 | Travel and Lodging Vemlidy · HBV · travel to Anaheim, CA · in-kind Company’s description;4174235;VEM US;10003083 | $196 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Mallinckrodt Hospital Products Inc. Jun 20, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $6,900 |
| Madrigal Pharmaceuticals Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Gilead Sciences, Inc. Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4121644;AHM;10003083 | $6,440 |
| Gilead Sciences, Inc. Jun 2, 2025 | Travel and Lodging Epclusa · HCV · travel to Traverse City, MI · in-kind Company’s description;4327752;AHM;10003083 | $890 |
| Gilead Sciences, Inc. May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4118485;AHM;10003083 | $3,790 |
| Gilead Sciences, Inc. May 23, 2025 | Travel and Lodging Epclusa · HCV · travel to Traverse City, MI · in-kind Company’s description;4124967;AHM;10003083 | $747 |
| Intercept Pharmaceuticals, Inc. Apr 27, 2025 | Consulting Fee OCALIVA · Hepatology / Gastroenterology | $1,860 |
| Gilead Sciences, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4113061;AHM;10003083 | $6,440 |
| Bausch Health US, LLC Mar 20, 2025 | Consulting Fee | $800 |
| Madrigal Pharmaceuticals Mar 19, 2025 | Consulting Fee REZDIFFRA · LIVER DISEASE | $8,460 |
| Madrigal Pharmaceuticals Mar 19, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to SAN ANTONIO, TX · in-kind | $143 |
| Madrigal Pharmaceuticals Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Mallinckrodt Hospital Products Inc. Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) TERLIVAZ · CRITICAL CARE | $2,070 |
| Madrigal Pharmaceuticals Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Gilead Sciences, Inc. Feb 22, 2025 | Travel and Lodging Epclusa · HCV · travel to San Diego, CA · in-kind Company’s description;4031405;GTF;10003083 | $697 |
| Ipsen Biopharmaceuticals, Inc Feb 8, 2025 | Compensation for services other than consulting (speaking, faculty) IQIRVO · Rare Disease | $4,590 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.